ResearcherDartmouth CollegeActive in the last 2 years

Jennifer R. Shell

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5494-0896; OpenAlex author ID A5026994976. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Radiation-Activated Cobalamin-Kinase Inhibitors for Treatment of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1021/acs.molpharmaceut.3c00667 ↗
Tumor targeting vitamin B12 derivatives for X-ray induced treatment of pancreatic adenocarcinoma. Last author DOI 10.1016/j.pdpdt.2019.101637 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Liberty N. Gendron · 2 shared papers, 2020–2024 · strength 0.38
- Paper Radiation-Activated Cobalamin-Kinase Inhibitors for Treatment of Pancreatic Ductal Adenocarcinoma. DOI 10.1021/acs.molpharmaceut.3c00667 ↗
- Paper Tumor targeting vitamin B12 derivatives for X-ray induced treatment of pancreatic adenocarcinoma. DOI 10.1016/j.pdpdt.2019.101637 ↗
Brian William Pogue · 2 shared papers, 2020–2024 · strength 0.38
- Paper Radiation-Activated Cobalamin-Kinase Inhibitors for Treatment of Pancreatic Ductal Adenocarcinoma. DOI 10.1021/acs.molpharmaceut.3c00667 ↗
- Paper Tumor targeting vitamin B12 derivatives for X-ray induced treatment of pancreatic adenocarcinoma. DOI 10.1016/j.pdpdt.2019.101637 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.